Literature DB >> 22837586

Synthesis of Hemigossypol and its Derivatives.

Jun Wei1, David L Vander Jagt, Robert E Royer, Lorraine M Deck.   

Abstract

Hemigossypol (3), a sesquiterpene natural product, was previously isolated from Gossypium barbadense and was shown to display improved anti-fungal activity compared to gossypol (1), the disesquiterpene dimer of hemigossypol (3). Gossypol exhibits multiple biological activities. In order to study whether hemigossypol and it derivatives retain the various bioactivities of gossypol, we developed a short and convenient synthetic scheme to synthesize hemigossypol. This is the first de novo synthesis of this natural product. In addition derivatives of hemigossypol with various 2,5-alkyl substituents were synthesized. Modification of the synthetic scheme also afforded the natural product hemigossylic lactone (4) and its 2,5-substituted derivatives.

Entities:  

Year:  2010        PMID: 22837586      PMCID: PMC3403735          DOI: 10.1016/j.tetlet.2010.08.089

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  15 in total

1.  Gossypol and derivatives: a new class of aldose reductase inhibitors.

Authors:  L M Deck; D L Vander Jagt; R E Royer
Journal:  J Med Chem       Date:  1991-11       Impact factor: 7.446

2.  Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles.

Authors:  R E Royer; L M Deck; N M Campos; L A Hunsaker; D L Vander Jagt
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

3.  Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.

Authors:  J W Jaroszewski; O Kaplan; J S Cohen
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

4.  Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.

Authors:  C Van Poznak; A D Seidman; M M Reidenberg; M M Moasser; N Sklarin; K Van Zee; P Borgen; M Gollub; D Bacotti; T J Yao; R Bloch; M Ligueros; M Sonenberg; L Norton; C Hudis
Journal:  Breast Cancer Res Treat       Date:  2001-04       Impact factor: 4.872

5.  Gossypol. Synthesis and in vitro spermicidal activity of isomeric hemigossypol derivatives.

Authors:  A Manmade; P Herlihy; J Quick; R P Duffley; M Burgos; A P Hoffer
Journal:  Experientia       Date:  1983-11-15

6.  Induction of Terpenoid Synthesis in Cotton Roots and Control of Rhizoctonia solani by Seed Treatment with Trichoderma virens.

Authors:  C R Howell; L E Hanson; R D Stipanovic; L S Puckhaber
Journal:  Phytopathology       Date:  2000-03       Impact factor: 4.025

7.  Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.

Authors:  L M Deck; R E Royer; B B Chamblee; V M Hernandez; R R Malone; J E Torres; L A Hunsaker; R C Piper; M T Makler; D L Vander Jagt
Journal:  J Med Chem       Date:  1998-09-24       Impact factor: 7.446

8.  Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds.

Authors:  R E Royer; L M Deck; T J Vander Jagt; F J Martinez; R G Mills; S A Young; D L Vander Jagt
Journal:  J Med Chem       Date:  1995-06-23       Impact factor: 7.446

9.  Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.

Authors:  Yang Meng; Wenhua Tang; Yao Dai; Xiaoqing Wu; Meilan Liu; Qing Ji; Min Ji; Kenneth Pienta; Theodore Lawrence; Liang Xu
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

10.  Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi.

Authors:  E E Montamat; C Burgos; N M Gerez de Burgos; L E Rovai; A Blanco; E L Segura
Journal:  Science       Date:  1982-10-15       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.